Biotech and pharma dealmaking is off to a good start in 2025. Meanwhile, digital health fundraising defined by “David and ...

Elevating Saudi Biotech to Global Heights Panel Lifera's summit in Riyadh highlighted Saudi Arabia's biotech potential, focusing on collabo ...

SAN DIEGO, CA and SOUTH SAN FRANCISCO, CA / / January 21, 2025 / Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ('Dermata') and Revance Therapeutics, Inc. (Nasdaq: RVNC) ('Revance' together ...

It’s always a good sign when a couple of big deals are announced right before the conference, and this year we saw a doozie ...

The reality is much more complicated, however, as these market-defining companies were not guaranteed to come out on top.

As the year gets underway, analysts and biotech executives highlight cell therapy’s pivot from oncology to autoimmune ...

In the late 19th century, Hartford built a cutting-edge reputation in manufacturing becoming one of the wealthiest cities in the country, crowned by the assembly-line innovation of Samuel Colt’s ...

Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in 2025.

Key Takeaways JNJ will buy Intra-Cellular Therapies, producer of a drug for bipolar disorder, for $14.6 billion. Eli Lilly ...

Billionaire pushes ahead with plans to infiltrate all parts of Trump’s administration after axing of his co-leader at DOGE ...

Verseon, a pioneering company in physics- and AI-powered drug discovery, revealed that its AI technology significantly ...